Global Veterinary-Animal Vaccines Market Size By Type Of Vaccine, By Target Species, By Disease Type, By Distribution Channel, By Geographic Scope And Forecast

Veterinary-Animal Vaccines Market Size And Forecast

Veterinary-Animal Vaccines Market size was valued at USD 10.55 Billion in 2023 and is projected to reach USD 18.28 Billion by 2031, growing at a CAGR of 6.9 % during the forecast period 2024-2031.

To Get Detailed Analysis: Please E-mail – ( avni@agninews.co.in) For FREE SAMPLE REPORT and mention Report Name

Global Veterinary-Animal Vaccines Market Drivers

The market drivers for the Veterinary-Animal Vaccines Market can be influenced by various factors. These may include:

• • Growing Pet Ownership: The demand for veterinary services, such as vaccinations to maintain the health and wellbeing of pets, is rising in tandem with the worldwide pet ownership trend.
• • Increasing Livestock Population: The world’s livestock population is growing as a result of the rising demand for meat and dairy products everywhere. The need for veterinary vaccines is fueled by the fact that vaccinations are essential in stopping the spread of diseases among cattle.
• • The prevalence of zoonotic diseases is on the rise. Zoonotic diseases are illnesses that people can contract from animals. Veterinary vaccine demand is expected to rise as a result of the increasing prevalence of these illnesses and the need to vaccinate animals in order to stop their spread.
• • Government attempts and rules: The veterinary animal vaccines industry is mostly driven by government attempts to manage and eradicate animal diseases as well as by rules requiring vaccination programs. These laws frequently mandate that owners of livestock vaccinate their animals, which sustains a consistent demand for veterinary vaccines.
• • Technological developments: The effectiveness and safety of veterinary vaccinations are improved by developments in vaccine technology, such as the creation of novel adjuvants and delivery methods. Innovation in the veterinary vaccines market is fueled by these technological developments, which result in the creation of new and enhanced products.
• • Growing Knowledge about Animal Health: Preventive healthcare practices, such as vaccination, are becoming increasingly important in preserving the health of animals. This knowledge is being recognized by veterinarians, livestock farmers, and pet owners. The market for veterinary vaccinations is expanding as a result of this greater knowledge.
• • An increase in disease outbreaks is seen in the need for efficient immunization programs to manage and stop the spread of infectious illnesses in animals, such as avian influenza and foot-and-mouth disease. The need for veterinary vaccinations as part of disease control strategies is fueled by these outbreaks.
• • Research and Development Investments: New vaccinations for livestock and companion animals are discovered and developed as a result of ongoing research and development funding provided by pharmaceutical corporations and governmental organizations. By addressing unmet requirements in animal healthcare and diversifying the product portfolio, this promotes market growth.

Global Veterinary-Animal Vaccines Market Restraints

Several factors can act as restraints or challenges for the Veterinary-Animal Vaccines Market. These may include:

• • Regulatory Obstacles: Tight regulations requiring vaccine approval may prevent the industry from expanding. Complying with these standards necessitates lengthy and expensive testing and approval procedures for vaccine producers.
• • Limited Knowledge: The expansion of the market may be hampered by pet owners’ and livestock producers’ ignorance of the value of vaccinations for animal health. Campaigns for education might be required to raise veterinary vaccine awareness and uptake.
• • High Costs: Veterinary vaccine production and research and development costs are frequently very high. Adoption may be restricted if these expenses are passed on to customers, particularly in areas with lower income levels or tighter budgets.
• • Logistical Challenges: Due to infrastructure constraints, such as insufficient cold chain storage facilities or transportation networks, distributing vaccinations to rural or remote areas, where many livestock businesses are located, can be difficult.
• • Vaccine Efficacy and Safety Concerns: Owners of animals may be reluctant to vaccinate their pets due to perceived or real concerns about vaccine efficacy or safety. The credibility of veterinary vaccinations may be damaged by reports of side effects or vaccination failures.
• • Competitive Landscape: There are many companies fighting for market share in the fiercely competitive veterinary vaccines sector. It could be harder for smaller businesses to get traction when competing against more established organizations that have well-known brands.
• • Eradication of Diseases: In certain situations, effective immunization campaigns may result in the eradication of particular diseases, which lowers the need for vaccinations that target those particular pathogens. Unless there is a need for revised vaccination formulations or new diseases emerge, this could hinder market growth.
• • Global Economic Conditions: Consumer spending on veterinary services, including vaccinations, may be impacted by economic downturns or instability in important markets. Some animal owners may decide not to provide their animals with non-essential healthcare services due to a reduction in disposable income.
• • Antibiotic Use in Animal Agriculture: There may be less emphasis on vaccination in areas where antibiotics are widely available and utilized as a primary method of disease prevention in livestock, which could limit the expansion of the veterinary vaccine industry.

Global Veterinary-Animal Vaccines Market Segmentation Analysis

The Global Veterinary-Animal Vaccines Market is Segmented on the basis of Type of Vaccine, Target Species, Disease Type, Distribution Channel and Geography.

Veterinary-Animal Vaccines Market, By Type of Vaccine

• Live Attenuated Vaccines: These vaccines contain weakened forms of the pathogen. They often provide strong and long-lasting immunity but may carry a risk of causing disease in susceptible animals.
• Inactivated Vaccines: These vaccines contain killed pathogens. They are safer but may require booster doses for sustained immunity.
• Recombinant Vaccines: These vaccines use genetically engineered components of the pathogen to stimulate immunity.
• DNA Vaccines: These vaccines use DNA fragments from the pathogen to trigger an immune response.

Veterinary-Animal Vaccines Market, By Target Species

• Canine Vaccines: Vaccines specifically designed for dogs.
• Feline Vaccines: Vaccines designed for cats.
• Bovine Vaccines: Vaccines for cattle.
• Poultry Vaccines: Vaccines tailored for birds such as chickens, turkeys, and ducks.
• Equine Vaccines: Vaccines for horses.
• Porcine Vaccines: Vaccines for pigs.

Veterinary-Animal Vaccines Market, By Disease Type

• Viral Vaccines: Vaccines targeting viral diseases such as rabies, distemper, and parvovirus.
• Bacterial Vaccines: Vaccines for bacterial diseases like leptospirosis, brucellosis, and salmonella.
• Parasitic Vaccines: Vaccines designed to prevent parasitic infections like Lyme disease, heartworm, and flea-borne diseases.
• Other Infectious Agents: Vaccines for diseases caused by fungi or other microorganisms.

Veterinary-Animal Vaccines Market, By Distribution Channel

• Veterinary Clinics: Vaccines distributed through veterinary clinics and hospitals.
• Veterinary Hospitals: Larger healthcare facilities for animals that may offer a broader range of vaccines.
• Retail Pharmacies: Some vaccines may be available through retail channels for pet owners to administer themselves.
• Online Channels: Increasingly, vaccines are being sold through online platforms, especially for livestock vaccines.

Veterinary-Animal Vaccines Market, By Geographic

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Key Players

The major players in the Veterinary-Animal Vaccines Market are

•  Zoetis
• Merck Animal Health
• Boehringer Ingelheim
• Elanco
• Ceva
• Virbac
• Vetoquinol
• Phibro Animal Health
• Hester
• Hipra,
• IdtBiologika
• Biogenesis Bago
• Tianjin Ringpu
• China Animal Husbandry
• Jinyu Bio-Technology

Report Scope

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

{“”@context””:””https:\/\/schema.org””,””@type””:””FAQPage””,””mainEntity””:[{“”@type””:””Question””,””name””:””What is the projected market size & growth rate of the Veterinary-Animal Vaccines Market?””,””acceptedAnswer””:{“”@type””:””Answer””,””text””:””Veterinary-Animal Vaccines Market was valued at USD 10.55 Billion in 2023 and is projected to reach USD 18.28 Billion by 2031, growing at a CAGR of 6.9 % during the forecast period 2024-2031.\n Read More..””}},{“”@type””:””Question””,””name””:””What are the key driving factors for the growth of the Veterinary-Animal Vaccines Market?””,””acceptedAnswer””:{“”@type””:””Answer””,””text””:””Growing Pet Ownership, Increasing Livestock Population, Government attempts and rules, and Technological developments are the factors driving the growth of the Veterinary-Animal Vaccines Market.\n Read More..””}},{“”@type””:””Question””,””name””:””What are the top players operating in the Veterinary-Animal Vaccines Market?””,””acceptedAnswer””:{“”@type””:””Answer””,””text””:””The major players are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Vetoquinol, Phibro Animal Health, Hester, Hipra,, Biogenesis Bago.\n Read More..””}},{“”@type””:””Question””,””name””:””What segments are covered in the Veterinary-Animal Vaccines Market report?””,””acceptedAnswer””:{“”@type””:””Answer””,””text””:””The Global Veterinary Animal Vaccines Market is Segmented on the basis of \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Type of Vaccine, Target Species, Disease Type, Distribution Channel and Geography.\n Read More..””}},{“”@type””:””Question””,””name””:””How can I get a sample report\/company profiles for the Veterinary-Animal Vaccines Market?””,””acceptedAnswer””:{“”@type””:””Answer””,””text””:””The sample report for the Veterinary-Animal Vaccines Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.\n Read More..””}}]}